Form 15-12G Nuvalent, Inc.
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-40671
NUVALENT, INC.
(Exact name of registrant as specified in its charter)
Nuvalent, Inc.
One Broadway, 14th Floor,
Cambridge, Massachusetts 02142
Tel: (857) 357-7000
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Class A Common stock, par value $0.0001 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) |
☒ | |
| Rule 12g-4(a)(2) |
☐ | |
| Rule 12h-3(b)(1)(i) |
☒ | |
| Rule 12h-3(b)(1)(ii) |
☐ | |
| Rule 15d-6 |
☐ | |
| Rule 15d-22(b) |
☐ |
Approximate number of holders of record as of the certification or notice date: 1*
| * | Pursuant to an Agreement and Plan of Merger, dated as of June 9, 2026, by and among Nuvalent, Inc., a Delaware corporation (the “Company”), GlaxoSmithKline LLC, a Delaware limited liability company (“Parent”), Harmony Row Acquisition Co., a Delaware corporation (“Purchaser”) and, solely for purposes of Section 9.14 thereof, GSK plc, a public limited company organized under the laws of England and Wales, Purchaser merged with and into the Company, with the Company continuing as the surviving corporation and as a wholly owned subsidiary of Parent. |
Pursuant to the requirements of the Securities Exchange Act of 1934, Nuvalent, Inc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: July 27, 2026
| Nuvalent, Inc. | ||
| By: | /s/ Justin Huang | |
| Name: | Justin Huang | |
| Title: | President and Secretary | |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bitcoin Price Prediction Eyes $72K as $5B Options Bet Builds and AlphaPepe Approaches Its Public Pricing Reset
- Vulcan Provides Update on NAFTA Arbitration
- Greenberg Traurig Adds Corporate Tax Shareholder Zak Morozov in California
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
